Abiopharma

🔍 Smelker Thomas (Executive)

Company: BEL FUSE INC /NJ (BELFB)

Report Date: 2026-03-15

Detailed Transactions and Holdings:

• Acquired 3,049 shares of Class B Common Stock (Direct)
  Date: 2026-03-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 3,049.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 62 shares of Class A Common Stock (Direct)
  Date: 2026-03-15 | Code: I | equity_swap_involved: 0 | shares_owned_after: 62.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Mr. Smelker was granted 3,049 restricted shares of Class B Common Stock on March 15, 2026. The restricted shares vest as follows: 1,016 shares vest as of March 15, 2027; 1,016 shares vest as of March 15, 2028; and 1,017 shares vest as of March 15, 2029.
• F2: The number of shares held in the 401(k) plan is estimated.